1 54300sek
0,0 %
Date:2026-08-11Time:14:11:16Latest report:Q2-2026List:Large CapTicker:AZN
Market Cap:2 391 693 msekEnterprise Value:2 652 761 msekNet Sales:61 366 musdEarnings:10 446 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 534,00
MA50:1 686,00
MA200:1 723,49
Price/MA200:-11,1 %
RSI (14):40,2
Price/MA50:-9,1 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.